EX-99.1 2 exhibit991.htm PRESS RELEASE exhibit991.htm
Exhibit 99.1
 
 
N E W S  R E L E A S E

Contact:
Investor Relations Inquiries
Edmund E. Kroll
 
Senior Vice President, Finance & Investor Relations
 
(212) 759-0382
 
 
Media Inquiries
 
Sandy McBride
 
Senior Director, Corporate Marketing & Communications
 
(314) 725-4477

FOR IMMEDIATE RELEASE

CENTENE CORPORATION REPORTS 2008 FOURTH QUARTER EARNINGS

ST. LOUIS, MISSOURI (February 10, 2009) -- Centene Corporation (NYSE: CNC) today announced its financial results for the quarter and year ended December 31, 2008.  As discussed on our December 19, 2008 guidance call, the results of operations for University Health Plans, or UHP, our New Jersey health plan, are now classified as discontinued operations as a result of our decision to sell certain assets of UHP.  Unless specifically noted, the discussions below are in the context of net earnings from continuing operations and all financial ratios are calculated using revenues excluding premium taxes and investment income.

           
2008 Highlights
 
Q4
   
Full Year
 
 Total Revenues (in millions)
$
902.8 
   
$
3,364.5 
 
 Consolidated HBR
 
82.3 
%
   
82.5
%
 Diluted EPS
$
0.53 
   
$
1.90
 
               

Fourth Quarter Highlights
 
·  
Quarter-end Medicaid Managed Care membership of 1.2 million.
 
·  
Revenues of $902.8 million, or $878.8 million net of premium taxes, a 22.2% increase over the 2007 fourth quarter.
 
·  
Health Benefits Ratio (HBR), which reflects medical costs as a percent of premium revenues, of 82.3%, compared to 85.3% in the 2007 fourth quarter.
 
·  
General and administrative (G&A) expense ratio of 13.8%, compared to 14.9% in the 2007 fourth quarter.
 
·  
Cash flow from operations of $95.5 million.
 
·  
Days in claims payable of 48.5.
 
·  
Diluted earnings per share, or EPS, from continuing operations of $0.53.  Total (including New Jersey) diluted EPS of $0.49, including a $0.05 one-time charge related to the sale of our New Jersey health plan.
 
 
Other Events
 
·  
In February 2009, we began converting membership in Florida from Access, on a non-risk basis, to our new subsidiary, Sunshine State Health Plan, on an at-risk basis.

·  
Peach State Health Plan, Inc., our Georgia subsidiary, received Accreditation Status by the National Committee for Quality Assurance (NCQA) under the New Health Plan Accreditation Program.

Michael F. Neidorff, Centene’s Chairman and Chief Executive Officer, stated, “We were pleased with the results of the fourth quarter and year, which reflect our focus on fundamentals that we will maintain going forward.”
 
 

 
The following table depicts membership in Centene’s managed care organizations, by state, at December 31, 2008 and 2007:

   
2008
 
2007
 
 Georgia
   
288,300
   
287,900
 
 Indiana
   
175,300
   
154,600
 
 Ohio
   
133,400
   
128,700
 
 South Carolina(a)
   
31,300
   
31,800
 
 Texas
   
431,700
   
354,400
 
 Wisconsin
   
124,800
   
131,900
 
 Total
   
1,184,800
   
1,089,300
 
  _______________              
(a) Substantially all of the 2007 membership in South Carolina was on a non-risk basis.
 
               

The following table depicts membership in Centene’s managed care organizations, by member category, at December 31, 2008 and 2007:

   
2008
 
2007
 
 Medicaid
   
862,500
   
807,600
 
 SCHIP/Foster Care
   
257,300
   
214,600
 
 ABD/Medicare
   
65,000
   
67,100
 
 Total
   
1,184,800
(a) 
 
1,089,300
(b)
   _______________              
(a) 1,181,100 at-risk; 3,700 ASO
             
(b) 1,054,200 at-risk; 35,100 ASO
             


Statement of Operations

·  
For the 2008 fourth quarter, revenues, net of premium taxes, increased 22.2% to $878.8 million from $719.4 million in the 2007 fourth quarter.  The increase was primarily driven by membership growth, especially related to the new Foster Care contract in Texas, premium rate increases and the recent acquisition of Celtic, which closed on July 1, 2008.
 
·  
The consolidated HBR, which reflects medical costs as a percent of premium revenues, was 82.3%, a decrease from 85.3% in the 2007 fourth quarter.  The decrease is primarily due to overall increased premium yield, a moderating medical cost trend and the acquisition of Celtic.  Sequentially, our consolidated HBR increased from 82.2% in the 2008 third quarter to 82.3%.
 
·  
Consolidated G&A expense as a percent of premium and service revenues was 13.8% in the fourth quarter of 2008, a decrease from 14.9% in the fourth quarter of 2007.  The decrease was due primarily to the restructuring charge recorded in the fourth quarter of 2007.
 
·  
Loss from discontinued operations in the fourth quarter of 2008 includes a $3.7 million pre-tax, or $0.05 per diluted share, charge primarily for asset impairments and employee severance related to the sale of our New Jersey health plan.
 
·  
For the year ended December 31, 2008, revenues, net of premium taxes, from continuing operations increased 21.6% to $3.3 billion from $2.7 billion for the same period in the prior year.  G&A expenses as a percent of premium and service revenues decreased to 13.6% in the year ended December 31, 2008, compared to 14.3% in the year ended December 31, 2007.  Earnings from operations increased to $131.6 million in the year ended December 31, 2008 from $55.3 million in the year ended December 31, 2007.  Net earnings from continuing operations, were $84.2 million, or $1.90 per diluted share in 2008.
 
·  
The following table reconciles diluted EPS from continuing operations to total diluted EPS:

 EPS Reconciliation:
     
Diluted EPS from continuing operations (1)
$
1.90 
 
Discontinued health plan operations
 
0.03 
 
New Jersey one-time exit charges
 
(0.05)
 
 Total diluted EPS
$
1.88 
 
_______________
     
(1) Includes $0.28 recorded during the first quarter of 2008 related to the Georgia premium rate increase for July 1, 2007 – December 31, 2007.
     
       

Balance Sheet and Cash Flow

At December 31, 2008, the Company had cash and investments of $822.1 million, including $798.0 million held by its regulated entities and $24.1 million held by its unregulated entities.  Medical claims liabilities totaled $373.0 million, representing 48.5 days in claims payable, an increase of 0.2 days from December 31, 2007 and an increase of 0.6 days from September 30, 2008.  Total debt was $264.9 million and debt to capitalization was 34.6%.  Year to date cash flow from operations was $222.0 million.
 
A reconciliation of the Company’s change in days in claims payable from the immediately preceding quarter-end is presented below:
 
 Days in claims payable, September 30, 2008
47.9
 
 State medical expense reconciliation
0.5
 
 Other
0.1
 
 Days in claims payable, December 31, 2008
48.5
 
     


Outlook

The table below depicts the Company’s annual guidance for 2009:

   
Full Year 2009
 
   
Low
 
High 
 
 Revenue (in millions) (1)
 
$    3,650
 
$  3,775
 
 Earnings per diluted share
 
$      1.82
 
$    1.94
 
_________________
         
(1) Revenue net of premium tax
         

The Company is maintaining its previously issued 2009 financial guidance.


Conference Call
 
As previously announced, the Company will host a conference call Tuesday, February 10, 2009, at 8:30 A.M. (Eastern Time) to review the financial results for the fourth quarter and year ended December 31, 2008, and to discuss its business outlook.  Michael F. Neidorff and Eric R. Slusser will host the conference call.  Investors are invited to participate in the conference call by dialing 800-273-1254 in the U.S. and Canada, 973-638-3440 from abroad, or via a live internet broadcast on the Company's website at www.centene.com, under the Investor Relations section.  A replay will be available for on-demand listening shortly after the completion of the call until 11:59 P.M. (Eastern Time) on February 24, 2009 at the aforementioned URL, or by dialing 800-642-1687 in the U.S. and Canada, or 706-645-9291 from abroad, and entering access code 81401888.

 
About Centene Corporation
 
Centene Corporation is a leading multi-line healthcare enterprise that provides programs and related services to individuals receiving benefits under Medicaid, including the State Children's Health Insurance Program (SCHIP), as well as Aged, Blind, or Disabled (ABD), Foster Care, Long-Term Care and Medicare (Special Needs Plans). The Company operates local health plans and offers a range of healthcare solutions for the rising number of uninsured Americans. It also contracts with other healthcare and commercial organizations to provide specialty services including behavioral health, life and health management, managed vision, nurse triage, pharmacy benefits management and treatment compliance. Information regarding Centene is available via the Internet at www.centene.com.
 

The information provided in this press release contains forward-looking statements that relate to future events and future financial performance of Centene.  Subsequent events and developments may cause the Company's estimates to change.  The Company disclaims any obligation to update this forward-looking financial information in the future.  Readers are cautioned that matters subject to forward-looking statements involve known and unknown risks and uncertainties, including economic, regulatory, competitive and other factors that may cause Centene's or its industry's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.  Actual results may differ from projections or estimates due to a variety of important factors, including Centene's ability to accurately predict and effectively manage health benefits and other operating expenses, competition, changes in healthcare practices, changes in federal or state laws or regulations, inflation, provider contract changes, new technologies, reduction in provider payments by governmental payors, major epidemics, disasters and numerous other factors affecting the delivery and cost of healthcare.  The expiration, cancellation or suspension of Centene's Medicaid Managed Care contracts by state governments would also negatively affect Centene.

 [Tables Follow]
 
 

 
CENTENE CORPORATION AND SUBSIDIARIES
 
CONSOLIDATED BALANCE SHEETS
(In thousands, except share data)

   
December 31,
 
   
2008
   
2007
 
ASSETS
           
Current assets:
           
Cash and cash equivalents of continuing operations
  $ 370,999     $ 267,305  
Cash and cash equivalents of discontinued operations
    8,100       1,279  
Total cash and cash equivalents
    379,099       268,584  
Premium and related receivables, net of allowance for uncollectible accounts of $595 and $258, respectively
    92,531       79,492  
Short-term investments, at fair value (amortized cost $108,469 and $46,193, respectively)
    109,393       46,074  
Other current assets
    75,333       39,382  
Current assets of discontinued operations other than cash
    9,987       12,807  
Total current assets
    666,343       446,339  
Long-term investments, at fair value (amortized cost $329,330 and $314,681, respectively)
    332,411       317,041  
Restricted deposits, at fair value (amortized cost $9,124 and $6,383, respectively)
    9,254       6,430  
Property, software and equipment, net
    175,858       135,883  
Goodwill
    163,380       138,862  
Intangible assets, net
    17,575       11,337  
Other long-term assets
    59,083       36,067  
Long-term assets of discontinued operations
    27,248       29,865  
Total assets
  $ 1,451,152     $ 1,121,824  
LIABILITIES AND STOCKHOLDERS’ EQUITY
               
Current liabilities:
               
Medical claims liability
  $ 373,037     $ 313,364  
Accounts payable and accrued expenses
    219,566       102,944  
Unearned revenue
    17,107       44,016  
Current portion of long-term debt
    255       971  
Current liabilities of discontinued operations
    31,013       25,505  
Total current liabilities
    640,978       486,800  
Long-term debt
    264,637       206,406  
Other long-term liabilities
    43,539       13,300  
Long-term liabilities of discontinued operations
    726       271  
Total liabilities
    949,880       706,777  
                 
Commitments and contingencies
               
                 
Stockholders’ equity:
               
Common stock, $.001 par value; authorized 100,000,000 shares; issued and outstanding 42,987,764 and 43,667,837 shares, respectively
    43       44  
Additional paid-in capital
    222,841       221,693  
Accumulated other comprehensive income:
               
Unrealized gain on investments, net of tax
    3,152       1,571  
Retained earnings
    275,236       191,739  
Total stockholders’ equity
    501,272       415,047  
Total liabilities and stockholders’ equity
  $ 1,451,152     $ 1,121,824  


 


 CENTENE CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except share data)

   
Three Months Ended
December 31,
   
Year Ended
December 31,
 
   
2008
   
2007
   
2008
   
2007
 
   
(Unaudited)
   
(Unaudited)
 
Revenues:
                       
Premium
  $ 860,811     $ 700,030     $ 3,199,360     $ 2,611,953  
Premium tax
    23,952       20,393       90,202       76,567  
Service
    17,995       19,399       74,953       80,508  
Total revenues
    902,758       739,822       3,364,515       2,769,028  
Operating expenses:
                               
Medical costs
    708,163       596,971       2,640,335       2,190,898  
Cost of services
    13,453       15,530       56,920       61,348  
General and administrative expenses
    121,343       107,159       444,733       384,970  
Premium tax
    24,329       20,393       90,966       76,567  
Total operating expenses
    867,288       740,053       3,232,954       2,713,783  
Earnings from operations
    35,470       (231 )     131,561       55,245  
Other income (expense):
                               
Investment and other income
    6,004       6,069       21,728       24,452  
Interest expense
    (4,237 )     (4,110 )     (16,673 )     (15,626 )
Earnings before income tax expense
    37,237       1,728       136,616       64,071  
Income tax expense
    13,971       97       52,435       23,031  
Net earnings from continuing operations
    23,266       1,631       84,181       41,040  
Discontinued operations, net of income tax (benefit) expense of $(671), $940, $(281), and $(31,563), respectively
    (1,843 )     (158 )     (684 )     32,362  
Net earnings
  $ 21,423     $ 1,473     $ 83,497     $ 73,402  
                                 
Net earnings per share:
                               
Basic:
                               
Continuing operations
  $ 0.54     $ 0.04     $ 1.95     $ 0.95  
Discontinued operations
    (0.04 )     (0.01 )     (0.02 )     0.74  
Basic earnings per common share
  $ 0.50     $ 0.03     $ 1.93     $ 1.69  
Diluted:
                               
Continuing operations
  $ 0.53     $ 0.04     $ 1.90     $ 0.92  
Discontinued operations
    (0.04 )     (0.01 )     (0.02 )     0.72  
Diluted earnings per common share
  $ 0.49     $ 0.03     $ 1.88     $ 1.64  
                                 
Weighted average number of shares outstanding:
                               
Basic
    42,957,593       43,574,811       43,275,187       43,539,950  
Diluted
    44,043,749       44,951,016       44,398,955       44,823,082  
                                 
 
 

 

CENTENE CORPORATION AND SUBSIDIARIES
 
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
 
   
Year Ended December 31,
 
   
2008
   
2007
 
Cash flows from operating activities:
               
Net earnings
 
$
83,497
   
$
73,402
 
Adjustments to reconcile net earnings to net cash provided by operating activities
               
Depreciation and amortization
   
35,414
     
27,807
 
Stock compensation expense
   
15,328
     
15,781
 
Loss on sale of investments, net
   
4,988
     
106
 
Gain on sale of FirstGuard Missouri
   
— 
     
(7,472
)
Impairment loss
   
2,546
     
7,207
 
Deferred income taxes
   
1,286
     
(10,223
)
Changes in assets and liabilities
               
Premium and related receivables
   
(1,548
   
1,663
 
Other current assets
   
(4,244
)
   
(6,253
)
Other assets
   
(2,700
   
(348
Medical claims liability
   
46,337
     
56,287
 
Unearned revenue
   
(36,447
   
10,085
 
Accounts payable and accrued expenses
   
75,112
     
31,234
 
Other operating activities
   
2,409
     
2,964
 
Net cash provided by operating activities
   
221,978
     
202,240
 
Cash flows from investing activities:
               
Capital expenditures
   
(65,156
)
   
(53,937
)
Purchase of investments
   
(549,652
)
   
(606,366
)
Sales and maturities of investments
   
546,264
     
456,738
 
Proceeds from asset sales
   
— 
     
14,102
 
Investments in acquisitions and equity method investee, net of cash acquired
   
(85,377
)
   
(36,001
)
Net cash used in investing activities
   
(153,921
)
   
(225,464
)
Cash flows from financing activities:
               
Proceeds from exercise of stock options
   
5,354
     
5,464
 
Proceeds from borrowings
   
236,005
     
212,000
 
Payment of long-term debt and notes payable
   
(178,491
)
   
(181,981
)
Excess tax benefits from stock compensation
   
3,100
     
— 
 
Common stock repurchases
   
(23,510
)
   
(9,541
)
Debt issue costs
   
— 
     
(5,181
)
Net cash provided by financing activities
   
42,458
     
20,761
 
Net increase (decrease) in cash and cash equivalents
   
110,515
     
(2,463
Cash and cash equivalents, beginning of period
   
268,584
     
271,047
 
Cash and cash equivalents, end of period
 
$
379,099
   
$
268,584
 
                 
Supplemental disclosures of cash flow information:
               
Interest paid
 
$
15,312
   
$
11,945
 
Income taxes paid
 
$
36,801
   
$
7,348
 
                 
Supplemental disclosure of non-cash investing and financing activities:
               
Property acquired under capital lease obligations
 
$
— 
   
$
1,736
 
 
 


CENTENE CORPORATION

CONTINUING OPERATIONS SUPPLEMENTAL FINANCIAL DATA

 
Q4
 
Q3
 
Q2
 
Q1
 
Q4
 
2008
 
2008
 
2008
 
2008
 
2007
MEMBERSHIP
                 
Managed Care:
                 
Georgia
288,300
 
283,900
 
278,800
 
282,700
 
287,900
Indiana
175,300
 
172,400
 
161,700
 
161,300
 
154,600
Ohio
133,400
 
132,500
 
137,300
 
131,100
 
128,700
South Carolina
31,300
 
26,600
 
22,500
 
29,300
 
31,800
Texas
431,700
 
436,900
 
427,200
 
369,000
 
354,400
Wisconsin
124,800
 
122,500
 
124,800
 
126,900
 
131,900
TOTAL
1,184,800
 
1,174,800
 
1,152,300
 
1,100,300
 
1,089,300
                   
Medicaid
862,500
 
850,500
 
828,700
 
823,600
 
807,600
SCHIP & Foster Care
257,300
 
261,800
 
256,900
 
206,300
 
214,600
ABD & Medicare
65,000
 
62,500
 
66,700
 
70,400
 
67,100
TOTAL
1,184,800
 
1,174,800
 
1,152,300
 
1,100,300
 
1,089,300
                   
Specialty Services(a):
                 
  Cenpatico Behavioral Health                  
Arizona
105,000
 
102,400
 
99,400
 
97,900
 
99,900
Kansas
41,100
 
40,100
 
40,000
 
39,400
 
39,000
  Bridgeway Health Solutions                  
Long-term Care
2,100
 
1,900
 
1,800
 
1,700
 
1,600
Acute Care
14,900
 
—       
 
—       
 
—       
 
—       
TOTAL
163,100
 
144,400
 
141,200
 
139,000
 
140,500
                   
(a) Includes external Specialty Service membership only.
               
                   
REVENUE PER MEMBER(b)
$
218.52
 
$
213.28
 
$
214.76
 
$
215.39
 
$
210.11
                   
CLAIMS(b)
                 
Period-end inventory
269,300
 
323,200
 
389,100
 
411,700
 
329,200
Average inventory
288,600
 
298,400
 
235,300
 
285,700
 
244,600
Period-end inventory per member
0.23
 
0.28
 
0.34
 
0.37
 
0.30
                   
(b) Revenue per member and claims information are presented for the Medicaid Managed Care segment.




 
Q4
 
Q3
 
Q2
 
Q1
 
Q4
 
2008
 
2008
 
2008
 
2008
 
2007
                   
DAYS IN CLAIMS PAYABLE (c)
48.5
 
47.9
 
47.8
 
48.3
 
48.3
(c) Days in Claims Payable is a calculation of Medical Claims Liabilities at the end of the period divided by average claims expense per calendar day for such period.
                   
CASH AND INVESTMENTS (in millions)
               
Regulated                                              
$
798.0
 
$
692.6
 
$
653.1
 
$
627.1
 
$
603.9
Unregulated                                              
 
24.1
   
26.8
   
29.0
   
25.8
   
33.0
TOTAL                                      
$
822.1
 
$
719.4
 
$
682.1
 
$
652.9
 
$
636.9
                   
DEBT TO CAPITALIZATION (d)
34.6%
 
34.4%
 
32.6%
 
32.8%
 
33.3%
(d) Debt to Capitalization is calculated as follows: total debt divided by (total debt + equity).

OPERATING RATIOS:

   
Three Months Ended
December 31,   
   
Year Ended
December 31,   
 
   
2008
   
2007
   
2008
   
2007
 
Health Benefits Ratios
                               
  Medicaid and SCHIP
   
80.3
%
   
83.7
%
   
80.6
%
   
82.8
%
  ABD and Medicare
   
90.1
     
94.4
     
91.1
     
91.4
 
  Specialty Services
   
85.4
     
78.5
     
83.8
     
78.4
 
  Total
   
82.3
     
85.3
     
82.5
     
83.9
 
                                 
General & Administrative Expense Ratios
                               
  Medicaid Managed Care
   
10.4
%
   
11.9
%
   
10.4
%
   
11.2
%
  Specialty Services
   
16.7
     
15.7
     
16.4
     
15.8
 
  Total
   
13.8
     
14.9
     
13.6
     
14.3
 

MEDICAL CLAIMS LIABILITIES (In thousands)
Four rolling quarters of the changes in medical claims liabilities are summarized as follows:

Balance, December 31, 2007
  $ 313,364  
Acquisitions
    15,398  
Incurred related to:
       
Current period
    2,659,036  
Prior period
    (18,701 )
Total incurred
    2,640,335  
Paid related to:
       
Current period
    2,303,473  
Prior period
    292,587  
Total paid
    2,596,060  
Balance, December 31, 2008
  $ 373,037  

Centene’s claims reserving process utilizes a consistent actuarial methodology to estimate Centene’s ultimate liability.  Any reduction in the “Incurred related to:  Prior period” claims may be offset as Centene actuarially determines “Incurred related to: Current period.”  As such, only in the absence of a consistent reserving methodology would favorable development of prior period claims liability estimates reduce medical costs.  Centene believes it has consistently applied its claims reserving methodology in each of the periods presented.